advanced search

Glycome BioPharma

Glycome BioPharma is applying its glycoscience technology to serve the global pharma and biopharma industry. The company has significant development capabilities in the field of organic chemistry for the development of novel methodologies, functional materials and their optimisation. 


Visit Website

Headquarters
Glycome BioPharma Ltd
Joyce House
Unit 4 Barrack Square
Ballincollig
Co Cork
P31 HW35
Ireland

Glycome BioPharma is a medical technology company that provides disruptive solutions to major challenges based on glycotechnology. It creates value through strategic alliances. The company is applying its knowledge in the field of glycoscience technology to serve the global pharma and biopharma industry.

Glycome BioPharma has significant development capabilities in the field of organic chemistry for the development of novel methodologies, functional materials and their optimisation, tailored to partners’ applications/products and manufacturing requirements.

The company is privately owned and was founded in 2018.

Articles by Glycome BioPharma

INJECTION
Dr Shane Smith
Pro-Tects – A NOVEL SOLUTION TO THE CHALLENGE OF BIOLOGIC INSTABILITY
Shane Smith, Eoin Scanlan and Paula Colavita discusses the difficulty inherent in developing parenteral biologic products due to the challenge of creating a stable formulation in the face of surface-mediated protein aggregation and introduces Pro-Tects – Glycome’s patented surface-treatment technology platform that offers a solution to this critical issue without introducing further development challenges.
PREFILLED SYRINGES
Dr Shane Smith
SURFACE-MEDIATED AGGREGATION – CONTROL OF THE LIQUID-SOLID INTERFACIAL STRESS
Shane Smith, Eoin Scanlan and Paula Colavita discuss how the company’s technology has evolved to create a stable and biocompatible coating that maintains device performance and safety.
Top